HomeCompareIMGO vs O

IMGO vs O: Dividend Comparison 2026

IMGO yields 5.55% · O yields 5.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 O wins by $5.4K in total portfolio value· pulled ahead in Year 8
10 years
IMGO
IMGO
● Live price
5.55%
Share price
$36.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.8K
Annual income
$791.76
Full IMGO calculator →
O
Realty Income Corporation
● Live price
5.28%
Share price
$61.15
Annual div
$3.23
5Y div CAGR
15.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.2K
Annual income
$5,102.74
Full O calculator →

Portfolio growth — IMGO vs O

📍 O pulled ahead of the other in Year 8

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIMGOO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IMGO + O cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IMGO pays
O pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IMGO
Annual income on $10K today (after 15% tax)
$472.09/yr
After 10yr DRIP, annual income (after tax)
$673.00/yr
O
Annual income on $10K today (after 15% tax)
$449.12/yr
After 10yr DRIP, annual income (after tax)
$4,337.33/yr
At 15% tax rate, O beats the other by $3,664.33/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IMGO + O for your $10,000?

IMGO: 50%O: 50%
100% O50/50100% IMGO
Portfolio after 10yr
$31.5K
Annual income
$2,947.25/yr
Blended yield
9.35%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on O right now

IMGO
Analyst Ratings
1
Buy
5
Hold
Consensus: Hold
Price Target
$36.00
-0.0% upside vs current
Range: $36.00 — $36.00
O
Analyst Ratings
13
Buy
18
Hold
3
Sell
Consensus: Hold
Price Target
$64.00
+4.7% upside vs current
Range: $60.00 — $69.00
Altman Z
1.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IMGO buys
0
O buys
0
No recent congressional trades found for IMGO or O in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIMGOO
Forward yield5.55%5.28%
Annual dividend / share$2.00$3.23
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.1%
Portfolio after 10y$28.8K$34.2K
Annual income after 10y$791.76$5,102.74
Total dividends collected$6.8K$20.7K
Payment frequencyquarterlymonthly
SectorStockREIT
Analyst consensusHoldHold
Analyst price target$36.00$64.00

Year-by-year: IMGO vs O ($10,000, DRIP)

YearIMGO PortfolioIMGO Income/yrO PortfolioO Income/yrGap
1$11,255$555.40$10,818$608.16+$437.00IMGO
2$12,628$584.23$11,787$741.68+$841.00IMGO
3$14,124$612.57$12,946$911.00+$1.2KIMGO
4$15,753$640.34$14,345$1,127.94+$1.4KIMGO
5$17,523$667.48$16,056$1,409.05+$1.5KIMGO
6$19,444$693.91$18,171$1,777.83+$1.3KIMGO
7$21,524$719.59$20,820$2,268.21+$704.00IMGO
8← crossover$23,776$744.48$24,188$2,929.90$412.00O
9$26,208$768.54$28,533$3,837.11$2.3KO
10$28,835$791.76$34,235$5,102.74$5.4KO

IMGO vs O: Complete Analysis 2026

IMGOStock

Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment of myeloproliferative neoplasms chronic cancers of the bone marrow, such as myelofibrosis, essential thrombocythemia, and polycythemia vera. The company was incorporated in 2012 and is headquartered in South San Francisco, California.

Full IMGO Calculator →

OREIT

Realty Income, The Monthly Dividend Company, is an S&P 500 company dedicated to providing stockholders with dependable monthly income. The company is structured as a REIT, and its monthly dividends are supported by the cash flow from over 6,500 real estate properties owned under long-term lease agreements with our commercial clients. To date, the company has declared 608 consecutive common stock monthly dividends throughout its 52-year operating history and increased the dividend 109 times since Realty Income's public listing in 1994 (NYSE: O). The company is a member of the S&P 500 Dividend Aristocrats index. Additional information about the company can be obtained from the corporate website at www.realtyincome.com.

Full O Calculator →
📬

Get this IMGO vs O comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IMGO vs SCHDIMGO vs JEPIIMGO vs KOIMGO vs MAINIMGO vs STAGIMGO vs ADCIMGO vs NNNIMGO vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.